Lorenzo Bomba retweeted
There are haploinsufficiencies that are caused almost entirely by missense variants instead of truncating mutations. Those genes are more vulnerable to missense variants disrupting their function, and SLC6A1 is an example. Here's our paper: cell.com/ajhg/fulltext/S0002…
Lorenzo Bomba retweeted
Published today, our reasons for optimism that success rates in drug discovery can be improved by picking the right targets using human genetics: nature.com/articles/s41586-0…
I break the key findings down panel by panel in this thread: xitter.cf/cureffi/status/1676896…
Is having even more gene-disease associations still useful for picking drug targets?
For which types of programs does it matter?
Has pharma shifted focus towards genetically validated targets?
New paper by me, @mnelsonxy, @DongCoco90417, & @jivecast doi.org/10.1101/2023.06.23.2…👇
Lorenzo Bomba retweeted
🌼 Spring @OpenTargets Platform release is out 🌼 Expanding beyond target identification, we have strengthened our ability to understand the effects of target modulation by assessing the direction of effect across our data sources. And this is just the tip of the iceberg... 🧵 – at East, England
Lorenzo Bomba retweeted
A paper that made a tremendous impact on both the academic and industry human geneticists, that was often cited as a key piece of reference in genetics start-up pitches to investors, that was instrumental behind some big investment decisions was published in @NatureGenet in 2015 by Matt Nelson (@mnelsonxy) and his colleagues (nature.com/articles/ng.3314).
Back then, Matt was heading the statistical genetics team at GSK. Intrigued by frequent references to the value of human genetics in drug development without empirical evidence, Matt, who was trained as a biostatistician decided to start a pet project to find if there is really any evidence to the claim that human genetics can help drug development. Matt wasn't expecting to find any. In fact, he started the project to show that there is no hard evidence. But to his surprise, he found the opposite: drug targets with human genetic support had a higher success rate than the ones without any human genetic support.
"We found that, among well-studied indications, the proportion of drug mechanisms with direct genetic support increases significantly across the drug development pipeline, from 2.0% at the preclinical stage to 8.2% among mechanisms for approved drugs, and varies dramatically among disease areas. We estimate that selecting genetically supported targets could double the success rate in clinical development."
To hear more about Matt's thoughts on the role of human genetics in drug development, his past at GSK for 15 years and his present as the VP of Genetics and Genomics at Deerfield Discovery, tune into this recent interview in The Genetics Podcast hosted by @patrick_j_short.
youtube.com/watch?v=Gbj47iZm…
Lorenzo Bomba retweeted
This is epic, thank you for making it happen cc @C_Glastonbury @BlagojeSoskic @CDominguezConde @AGiustacchini @NPirastu @Supergecko @FedeSanto95
Academics outside the US can now apply to access @AllofUsResearch. Please spread the word!
allofus.nih.gov/news-events/…
cc: @dgmacarthur @ceclindgren @timfrayling @minouye271 @nicolesoranzo @GLettre @samrip @ShaiCarmi @jgustavsmith @andganna @PaulLacaze @drjamesware @nickywhiffin
Lorenzo Bomba retweeted
Academics outside the US can now apply to access @AllofUsResearch. Please spread the word!
allofus.nih.gov/news-events/…
cc: @dgmacarthur @ceclindgren @timfrayling @minouye271 @nicolesoranzo @GLettre @samrip @ShaiCarmi @jgustavsmith @andganna @PaulLacaze @drjamesware @nickywhiffin
Lorenzo Bomba retweeted
How do different sources of gene burden compare?
The Open Targets Platform has become the reference repository for associations based on collapsing analyses — what does each analysis bring?
🧵
Lorenzo Bomba retweeted
Open computational postdoc position in my group @humantechnopole to study the regulation of B cell activation. Please get in touch if you’re interested.
careers.humantechnopole.it/o…
🙏 Please RT
Lorenzo Bomba retweeted
OUT NOW in @NAR_Open
A look back on how, in the past 2 years, the Open Targets Platform has been
Reimagined
Redesigned
Rebuilt
academic.oup.com/nar/article…
Lorenzo Bomba retweeted
We are looking for a research administrator for the Genomics Research Centre @humantechnopole (maternity cover). Please get in touch if you are interested, and RT 😍. careers.humantechnopole.it/o…
Lorenzo Bomba retweeted
Cool WGS paper looking at the associations of structural variants with hematologic traits in the TOPMed cohort (N=50,675).
nature.com/articles/s41467-0…
Lorenzo Bomba retweeted
Great to see our work from the CARDIoGRAMplusC4D Consortium on the genetics of coronary artery disease finally out in Nature Genetics nature.com/articles/s41588-0…
A short 🧵 to highlight some key findings..... 1/8
Lorenzo Bomba retweeted
And if you enjoyed @Eric_Fauman's causal gene:metabolite relationships, you may also like our earlier work in INTERVAL using WES in ~6000 participants to identify metabolite-associated genes using ultra-rare coding variants with @LoryBomb @nicolesoranzo and others:
Our paper identifying rare genetic variants associations with human plasma metabolite levels using sequencing data is now out in The American Journal of Human Genetics!! doi.org/10.1016/j.ajhg.2022.… 🧵🧵 1/12
Lorenzo Bomba retweeted
Are we really up to the penultimate installment of Seven Days of Novel Causal Genes?
Yes, yes we are.
Could there really be more totally novel yet totally probable causal genes left to be found?
Yes, yes there are.
Dig in
Lorenzo Bomba retweeted
If you've been waiting all day for the solution to day 5 of Seven Days of Novel Causal Genes, thanks for your patience.
So let's get right to it.
Lorenzo Bomba retweeted
Are you ready for day 4 of Seven Days of Novel Causal Genes?
Then join me as we leap down a rabbit hole in search of a causal gene for arabitol
pubmed.ncbi.nlm.nih.gov/3635…
Lorenzo Bomba retweeted
After 17 years of GWAS studies could there really be any novel causal genes that have never been seen before?
Let’s find out as we continue our adventures in 7 days of novel causal genes
Ripped from the pages of pubmed.ncbi.nlm.nih.gov/3635…
Lorenzo Bomba retweeted
7 days of novel causal genes. Day 2!
Another day, another causal gene that's never been seen in any GWAS before
pubmed.ncbi.nlm.nih.gov/3635…
Lorenzo Bomba retweeted
Here we go!
7 days of novel causal genes.
Gleaned from the pages of
"Rare and common genetic determinants of metabolic individuality and their effects on human health"
pubmed.ncbi.nlm.nih.gov/3635…




























